Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2013 Jan 9;3(4):299–308. doi: 10.1007/s13346-012-0124-9

Figure 6.

Figure 6

Cell viability assay (MTS assay) with Dox-PLGA nanoparticles and blank PLGA nanoparticles to show the inherent therapeutic efficacy of the Dox from the nanoparticles. The assay was done with HeLa and PC3 cell lines after 24h incubation time with both nanoparticle formulations.